Table of Contents
ISRN Endocrinology
Volume 2011, Article ID 481371, 6 pages
http://dx.doi.org/10.5402/2011/481371
Research Article

Abnormal Glucose Metabolism in Hispanic Parents of Children with Acanthosis Nigricans

1Department of Management, Policy, and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
2Department of Internal Medicine, Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
3Center for Diabetes and Metabolic Disorders, Department of Internal Medicine, Texas Tech University Health Sciences Center, Permian Basin Campus, 701 W 5th Street, Odessa, TX 79763, USA
4Cook Children's Physician Network, Fort Worth, TX 76104, USA
5Department of Behavioral and Community Health, School of Public Health, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
6Department of Molecular Biology and Immunology, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX 76107, USA

Received 18 October 2011; Accepted 13 November 2011

Academic Editors: C. Bizzarri and J. Vrbikova

Copyright © 2011 Ximena Urrutia-Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Burke, “Obesity in childhood and cardiovascular risk,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 831–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Kerem, H. Guttmann, and Z. Hochberg, “The autosomal dominant trait of obesity, acanthosis nigricans, hypertension, ischemic heart disease and diabetes type 2,” Hormone Research, vol. 55, no. 6, pp. 298–304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. P. D. Gluckman, M. A. Hanson, and A. S. Beedle, “Non-genomic transgenerational inheritance of disease risk,” BioEssays, vol. 29, no. 2, pp. 145–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Rader, “Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus,” American Journal of Medicine, vol. 120, no. 3, supplement 1, pp. S12–S18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. American Diabetes Association, “Type 2 diabetes in children and adolescents,” Pediatrics, vol. 105, no. 3, pp. 671–680, 2000. View at Google Scholar · View at Scopus
  6. C. A. Stuart, M. S. Driscoll, K. F. Lundquist, C. R. Gilkison, S. Shaheb, and M. M. Smith, “Acanthosis nigricans,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 9, no. 2–4, pp. 407–418, 1998. View at Google Scholar · View at Scopus
  7. P. Litonjua, A. Piñero-Piloña, L. Aviles-Santa, and P. Raskin, “Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes,” Endocrine Practice, vol. 10, no. 2, pp. 101–106, 2004. View at Google Scholar · View at Scopus
  8. M. L. Stoddart, K. S. Blevins, E. T. Lee, W. Wang, and P. R. Blackett, “Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee diabetes study,” Diabetes Care, vol. 25, no. 6, pp. 1009–1014, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ten and N. Maclaren, “Insulin resistance syndrome in children,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2526–2539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Stuart, C. J. Pate, and E. J. Peters, “Prevalence of acanthosis nigricans in an unselected population,” American Journal of Medicine, vol. 87, no. 3, pp. 269–272, 1989. View at Google Scholar · View at Scopus
  11. C. I. Friedman, S. Richards, and M. H. Kim, “Familial acanthosis nigricans. A longitudinal study,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 32, no. 7, pp. 531–536, 1987. View at Google Scholar · View at Scopus
  12. K. Harwood, P. Vuguin, and J. DiMartino-Nardi, “Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth,” Hormone Research, vol. 68, no. 5, pp. 209–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Mekhail and M. Markman, “Acanthosis nigricans with endometrial carcinoma: case report and review of the literature,” Gynecologic Oncology, vol. 84, no. 2, pp. 332–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sinha, G. Fisch, B. Teague et al., “Prevalence of impaired glucose tolerance among children and adolescents with marked obesity,” The New England Journal of Medicine, vol. 346, no. 11, pp. 802–810, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Sherwin, R. M. Anderson, and J. B. Buse, “American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases: prevention or delay of type 2 diabetes,” Diabetes Care, vol. 27, supplement 1, pp. S47–S54, 2004. View at Google Scholar
  16. D. M. Nathan, M. B. Davidson, R. A. DeFronzo et al., “Impaired fasting glucose and impaired glucose tolerance: implications for care,” Diabetes Care, vol. 30, no. 3, pp. 753–759, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Switzer and D. C. Hess, “Statin therapy for coronary heart disease and its effect on stroke,” Current Atherosclerosis Reports, vol. 8, no. 4, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shamoon, P. Cleary, A. Barnie et al., “Epidemiology of diabetes interventions and complications (EDIC): design, implementation, and preliminary results of a long-term follow-up of the diabetes control and complications trial cohort,” Diabetes Care, vol. 22, no. 1, pp. 99–111, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Genuth, “The UKPDS and its global impact,” Diabetic Medicine, vol. 25, supplement 2, pp. 57–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. W. B. Kannel, “Some lessons in cardiovascular epidemiology from Framingham,” American Journal of Cardiology, vol. 37, no. 2, pp. 269–282, 1976. View at Google Scholar · View at Scopus
  21. C. Rotimi, R. Cooper, G. Cao, C. Sundarum, and D. McGee, “Familial aggregation of cardiovascular diseases in African-American pedigrees,” Genetic Epidemiology, vol. 11, no. 5, pp. 397–407, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. R. R. Williams, S. C. Hunt, G. Heiss et al., “Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study),” American Journal of Cardiology, vol. 87, no. 2, pp. 129–135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Urrutia-Rojas, J. Menchaca, W. Wadley et al., “Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM),” Journal of Adolescent Health, vol. 34, no. 4, pp. 290–299, 2004. View at Publisher · View at Google Scholar · View at Scopus